🇺🇸 FDA
Patent

US 7070771

Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells

granted A61KA61K2039/51A61K48/00

Quick answer

US patent 7070771 (Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells) held by The Regents of the University of California expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/51, A61K48/00, A61P, A61P35/00